A new form of polypharmacy?
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents